About company
(Note: They are offering 2,065,935 units of NexGel, Inc., with each unit consisting of one share of their common stock, par value $0.001 per share, and one warrant to purchase one share of their common stock, in a firm commitment underwritten offering. Each warrant contained in a unit has an exercise price of $6.825 per share of common stock. The proposed stock symbol is “NXGL” and the proposed symbol for the warrant is “NXGLW.”)We manufacture high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery and cosmetics. They specialize in custom gels by capitalizing on proprietary manufacturing technologies. They have historically served as a contract manufacturer, supplying their gels to third parties who incorporate them into their own products and have recently began producing their own consumer products using their gels focused on proprietary branded products and white label opportunities. Both their gels and their consumer products are manufactured using proprietary and non-proprietary mixing, coating and cross-linking technologies. Together, these technologies enable them to produce gels that can satisfy rigid tolerance specifications with respect to a wide range of physical characteristics (e.g., thickness, water content, adherence, absorption, moisture vapor transmission rate (a measure of the passage of water vapor through a substance) and release rate) while maintaining product integrity. Additionally, they have the manufacturing ability to offer broad choices in the selection of liners onto which the gels are coated. Consequently, they and their customers are able to determine tolerances in moisture vapor transmission rate and active ingredient release rates while personalizing color and texture.
Industry
|
Wound Care Gels/ Transdermal Gels
|
Employees
|
Founded
|
10
|
2009
|